83 FR 8886 - National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 83, Issue 41 (March 1, 2018)

Page Range		8886-8886
FR Document		2018-04119

Federal Register, Volume 83 Issue 41 (Thursday, March 1, 2018)

[Federal Register Volume 83, Number 41 (Thursday, March 1, 2018)]
[Notices]
[Page 8886]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-04119]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Arthritis and Musculoskeletal and Skin 
Diseases; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Arthritis and Musculoskeletal and Skin 
Diseases Initial Review Group; Arthritis and Musculoskeletal and 
Skin Diseases Special Grants Review Committee.
    Date: March 15-16, 2018.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, 
Bethesda, MD 20817.
    Contact Person: Nakia C. Brown, Ph.D., Scientific Review 
Officer, National Institute of Arthritis and Musculoskeletal and 
Skin Diseases, National Institutes of Health, 6701 Democracy 
Boulevard, Suite 816, Bethesda, MD 20817, 301-827-4905, 
nikia.brown@nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.846, 
Arthritis, Musculoskeletal and Skin Diseases Research, National 
Institutes of Health, HHS)

    Dated: February 23, 2018.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-04119 Filed 2-28-18; 8:45 am]
BILLING CODE 4140-01-P

8886 Federal Register / Vol. 83, No. 41 / Thursday, March 1, 2018 / Notices

open public hearing session, FDA may Time: 8:00 a.m. to 5:00 p.m. Dynamic Interactions between Systemic or
conduct a lottery to determine the Agenda: To review and evaluate grant Non-Neuronal Systems and the Brain in
speakers for the scheduled open public applications. Aging and in Alzheimer’s Disease.
Place: Bethesda Marriott Suites, 6711 Date: March 8, 2018.
hearing session. The contact person will Time: 11:00 a.m. to 6:00 p.m.
Democracy Boulevard, Bethesda, MD 20817.
notify interested persons regarding their Contact Person: Nakia C. Brown, Ph.D., Agenda: To review and evaluate grant
request to speak by March 15, 2018. Scientific Review Officer, National Institute applications.
Persons attending FDA’s advisory of Arthritis and Musculoskeletal and Skin Place: National Institutes of Health, 6701
committee meetings are advised that the Diseases, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892
Agency is not responsible for providing Democracy Boulevard, Suite 816, Bethesda, (Telephone Conference Call).
access to electrical outlets. MD 20817, 301–827–4905, nikia.brown@ Contact Person: Inese Z. Beitins, MD,
FDA welcomes the attendance of the nih.gov. Scientific Review Officer, Center for
(Catalogue of Federal Domestic Assistance Scientific Review, National Institutes of
public at its advisory committee
Program Nos. 93.846, Arthritis, Health, 6701 Rockledge Drive, Room 6152,
meetings and will make every effort to MSC 7892, Bethesda, MD 20892, 301–435–
accommodate persons with disabilities. Musculoskeletal and Skin Diseases Research,
National Institutes of Health, HHS) 1034, beitinsi@csr.nih.gov.
If you require accommodations due to a This notice is being published less than 15
disability, please contact AnnMarie Dated: February 23, 2018. days prior to the meeting due to the timing
Williams, at annmarie.williams@ Sylvia L. Neal, limitations imposed by the review and
fda.hhs.gov, 301–796–5966 at least 7 Program Analyst, Office of Federal Advisory funding cycle.
days in advance of the meeting. Committee Policy. Name of Committee: Center for Scientific
FDA is committed to the orderly [FR Doc. 2018–04119 Filed 2–28–18; 8:45 am] Review Special Emphasis Panel;
conduct of its advisory committee BILLING CODE 4140–01–P
Collaborative Minority Health and Health
meetings. Please visit our website at Disparities Research with Tribal
Epidemiology Centers.
https://www.fda.gov/Advisory
Date: March 8, 2018.
Committees/AboutAdvisoryCommittees/ DEPARTMENT OF HEALTH AND Time: 1:00 p.m. to 3:30 p.m.
ucm111462.htm for procedures on HUMAN SERVICES Agenda: To review and evaluate grant
public conduct during advisory applications.
committee meetings. National Institutes of Health Place: National Institutes of Health, 6701
Notice of this meeting is given under Rockledge Drive, Bethesda, MD 20892
the Federal Advisory Committee Act (5 Center for Scientific Review; Notice of (Telephone Conference Call).
U.S.C. app. 2). Closed Meetings Contact Person: Delia Olufokunbi Sam,
Ph.D., Scientific Review Officer, Center for
Dated: February 23, 2018. Pursuant to section 10(d) of the Scientific Review, National Institutes of
Leslie Kux, Federal Advisory Committee Act, as Health, 6701 Rockledge Drive, Room 3158,
Associate Commissioner for Policy. amended, notice is hereby given of the MSC 7770, Bethesda, MD 20892, 301–435–
[FR Doc. 2018–04167 Filed 2–28–18; 8:45 am]
following meetings. 0684, olufokunbisamd@csr.nih.gov.
The meetings will be closed to the This notice is being published less than 15
BILLING CODE 4164–01–P
public in accordance with the days prior to the meeting due to the timing
provisions set forth in sections limitations imposed by the review and
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., funding cycle.
DEPARTMENT OF HEALTH AND Name of Committee: Center for Scientific
as amended. The grant applications and
HUMAN SERVICES Review Special Emphasis Panel; Fellowships
the discussions could disclose
Overflow: Risk, Prevention and Health
National Institutes of Health confidential trade secrets or commercial Behavior.
property such as patentable material, Date: March 9, 2018.
National Institute of Arthritis and and personal information concerning Time: 8:00 a.m. to 6:00 p.m.
Musculoskeletal and Skin Diseases; individuals associated with the grant Agenda: To review and evaluate grant
Notice of Closed Meeting applications, the disclosure of which applications.
would constitute a clearly unwarranted Place: The Dupont Hotel, 1500 New
Pursuant to section 10(d) of the invasion of personal privacy. Hampshire Avenue NW, Washington, DC
Federal Advisory Committee Act, as 20036.
amended, notice is hereby given of the Name of Committee: Center for Scientific Contact Person: Lee S. Mann, Ph.D.,
Review Special Emphasis Panel; Scientific Review Officer, Center for
following meeting.
Epidemiology of Chronic and Infectious Scientific Review, National Institutes of
The meeting will be closed to the Disease. Health, 6701 Rockledge Drive, Room 3224,
public in accordance with the Date: March 5, 2018. MSC 7808, Bethesda, MD 20892, 301–435–
provisions set forth in sections Time: 11:00 a.m. to 3:00 p.m. 0677, mannl@csr.nih.gov.
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Agenda: To review and evaluate grant This notice is being published less than 15
as amended. The grant applications and applications. days prior to the meeting due to the timing
the discussions could disclose Place: National Institutes of Health, 6701 limitations imposed by the review and
confidential trade secrets or commercial Rockledge Drive, Bethesda, MD 20892 funding cycle.
property such as patentable material, (Virtual Meeting).
Contact Person: Kate Fothergill, Ph.D., Name of Committee: Center for Scientific
and personal information concerning Scientific Review Officer, Center for
Review Special Emphasis Panel; Member
individuals associated with the grant Conflict: Molecular Sciences and
Scientific Review, National Institutes of
applications, the disclosure of which Technology.
Health, 6701 Rockledge Drive Room 3142,
would constitute a clearly unwarranted Date: March 9, 2018.
Bethesda, MD 20892, 301–435–2309,
amozie on DSK30RV082PROD with NOTICES

Time: 10:00 a.m. to 1:00 p.m.
invasion of personal privacy. fothergillke@mail.nih.gov.
Agenda: To review and evaluate grant
Name of Committee: Arthritis and This notice is being published less than 15 applications.
Musculoskeletal and Skin Diseases Initial days prior to the meeting due to the timing Place: National Institutes of Health, 6701
Review Group; Arthritis and Musculoskeletal limitations imposed by the review and Rockledge Drive, Bethesda, MD 20892
and Skin Diseases Special Grants Review funding cycle. (Telephone Conference Call).
Committee. Name of Committee: Center for Scientific Contact Person: Raj K. Krishnaraju, Ph.D.,
Date: March 15–16, 2018. Review Special Emphasis Panel; PAR17–029: Scientific Review Officer, Center for

VerDate Sep<11>2014 17:26 Feb 28, 2018 Jkt 244001 PO 00000 Frm 00057 Fmt 4703 Sfmt 4703 E:\FR\FM\01MRN1.SGM 01MRN1

Document Created: 2018-02-28 23:57:50
Document Modified: 2018-02-28 23:57:50

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		March 15-16, 2018.
FR Citation		83 FR 8886

83 FR 8886 - National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 83, Issue 41 (March 1, 2018)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health